Hanmi Science (008930) - Total Liabilities

Latest as of December 2025: ₩529.85 Billion KRW ≈ $359.07 Million USD

Based on the latest financial reports, Hanmi Science (008930) has total liabilities worth ₩529.85 Billion KRW (≈ $359.07 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 008930 operating cash flow to assess how effectively this company generates cash.

Hanmi Science - Total Liabilities Trend (2000–2025)

This chart illustrates how Hanmi Science's total liabilities have evolved over time, based on quarterly financial data. Check 008930 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Hanmi Science Competitors by Total Liabilities

The table below lists competitors of Hanmi Science ranked by their total liabilities.

Company Country Total Liabilities
Veridis Environment Ltd
TA:VRDS
Israel ILA3.52 Billion
Amara Raja Batteries Limited
NSE:ARE&M
India Rs31.10 Billion
Anhui Xinhua Media Co Ltd
SHG:601801
China CN¥7.49 Billion
Beijing Bei Mo Gao Ke Friction Mate
SHE:002985
China CN¥1.13 Billion
Shanghai Geoharbour Construction Group Co Ltd
SHG:605598
China CN¥490.52 Million
Deepak Fertilizers and Petrochemicals Corporation Limited
NSE:DEEPAKFERT
India Rs78.70 Billion
NP3 Fastigheter AB
ST:NP3
Sweden Skr16.83 Billion
Cimpress NV
NASDAQ:CMPR
USA $2.62 Billion

Liability Composition Analysis (2000–2025)

This chart breaks down Hanmi Science's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hanmi Science stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.88 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.55 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.36 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hanmi Science's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hanmi Science (2000–2025)

The table below shows the annual total liabilities of Hanmi Science from 2000 to 2025.

Year Total Liabilities Change
2025-12-31 ₩529.85 Billion
≈ $359.07 Million
+3.82%
2024-12-31 ₩510.38 Billion
≈ $345.87 Million
+16.34%
2023-12-31 ₩438.70 Billion
≈ $297.30 Million
+13.96%
2022-12-31 ₩384.94 Billion
≈ $260.87 Million
+48.28%
2021-12-31 ₩259.60 Billion
≈ $175.93 Million
-1.85%
2020-12-31 ₩264.49 Billion
≈ $179.24 Million
-0.25%
2019-12-31 ₩265.15 Billion
≈ $179.69 Million
+0.64%
2018-12-31 ₩263.45 Billion
≈ $178.54 Million
-3.72%
2017-12-31 ₩273.63 Billion
≈ $185.44 Million
-14.94%
2016-12-31 ₩321.68 Billion
≈ $218.00 Million
-7.50%
2015-12-31 ₩347.77 Billion
≈ $235.68 Million
+6.98%
2014-12-31 ₩325.08 Billion
≈ $220.30 Million
+90.38%
2013-12-31 ₩170.76 Billion
≈ $115.72 Million
+86.62%
2012-12-31 ₩91.50 Billion
≈ $62.01 Million
+169.83%
2011-12-31 ₩33.91 Billion
≈ $22.98 Million
-92.02%
2010-12-31 ₩424.95 Billion
≈ $287.98 Million
-5.69%
2009-12-31 ₩450.57 Billion
≈ $305.34 Million
+1.15%
2008-12-31 ₩445.43 Billion
≈ $301.86 Million
+31.25%
2007-12-31 ₩339.39 Billion
≈ $230.00 Million
+44.80%
2006-12-31 ₩234.39 Billion
≈ $158.84 Million
+23.83%
2005-12-31 ₩189.29 Billion
≈ $128.28 Million
+3.40%
2004-12-31 ₩183.07 Billion
≈ $124.06 Million
+6.31%
2003-12-31 ₩172.20 Billion
≈ $116.70 Million
+8.25%
2002-12-31 ₩159.07 Billion
≈ $107.80 Million
-3.08%
2001-12-31 ₩164.13 Billion
≈ $111.23 Million
+5.05%
2000-12-31 ₩156.24 Billion
≈ $105.88 Million
--

About Hanmi Science

KO:008930 Korea Medical Distribution
Market Cap
$1.73 Billion
₩2.55 Trillion KRW
Market Cap Rank
#6808 Global
#187 in Korea
Share Price
₩37700.00
Change (1 day)
-0.79%
52-Week Range
₩28500.00 - ₩51900.00
All Time High
₩138933.39
About

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition… Read more